[ad_1]
Vaccine enthusiasm wanes and Europe’s futures tumble
Futures for European and North American stocks were down again in the session leading up to Tuesday’s opening, at a time when enthusiasm for the coronavirus vaccine is waning.
At this point, futures for the Stoxx 50, an index that brings together the 50 most traded in Europe, fell 0.6%, while futures for the North American S&P 500 lost 0.5%.
After a new day of euphoria experienced yesterday, with Moderna announcing a 94.5% success rate for its vaccine, global rates are correcting today. Europe has been at highs since February, and on Wall Street, the S&P 500 closed at a new all-time high.
During the early morning in Lisbon, the Asian session oscillated between gains and losses with the good behavior recorded in Japan (0.2%), but setbacks in China (-0.3%).
Still, investors continue to focus on the sectors that benefit the most from economic growth, such as banking or oil. In contrast, the most defensive sectors that have benefited the most from the current pandemic, such as technology, are those that suffer the greatest drops.
In the United States, the American manufacturer of electric vehicles Tesla announced yesterday, after the close of the session, that it will begin trading in the S&P 500 index already in the session on December 21. The news caused the company to shoot more than 13% in “after hours”.
[ad_2]
